Benzonatate Capsule
Product Images NDC 68071-1395

2 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 68071-1395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 1395 3)

Pdp (68071 1395 3)
Benzonatate 200 mg capsules packaging label from NuCare Pharmaceuticals, Inc. The label states the product contains 30 oval-shaped clear yellow softgel capsules imprinted with "PC15." The label includes prescription-only (Rx) designation and storage instructions at controlled temperature 68-77°F. It displays the NDC 68071-1395-3 and product number P1395030, along with manufacturing details by Humanwell PuraCap Pharmaceutical in Wuhan, China.*
FDA Label Image

Structure Formula (Structure Formula)

Structure Formula (Structure Formula)
Chemical structure diagram of benzonatate showing its molecular formula C30H53NO11, including a benzene ring and attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.